| Name | Title | Contact Details |
|---|
Avedon Health Systems is a Saint Petersburg, FL-based company in the Software and Internet sector.
Bryght is a Vancouver, BC-based company in the Software & Internet sector.
Enspark is a Pleasant Grove, UT-based company in the Software and Internet sector.
Rasa is the leading conversational AI platform, enabling enterprises to build a next-level customer experience. Rasa`s platform was built to create enterprise-grade virtual assistants, allowing personalized conversations with customers - at scale. Rasa`s conversational AI platform allows companies to build better customer experiences by lowering costs through automation, improving customer satisfaction, and providing a scalable way to gather customer intelligence. Rasa`s platform is powered by Rasa Open Source, which has seen more than 10 million downloads since launch, and is supported by a friendly, fast-growing community learning from each other and working together to make better text- and voice-based AI assistants. Rasa runs in production everywhere from startups to Fortune 500s, and provides the data privacy, security, and scalability needed by enterprises of every size. Rasa is privately held, with funding from Accel, Andreessen Horowitz, Basis Set Ventures, and others. Individual investors include Daniel Dines, founder and CEO of UIPath, Ross Mason, founder of Mulesoft, and Greg Brockman, co-founder and CTO of OpenAI. Rasa was founded in 2016 and has offices in San Francisco, Berlin, and Edinburgh, in addition to remote employees based around the globe.
Castor is a leading provider of clinical trial technology that automates the research process. Castor is helping Democratize Clinical Research and making DCTs scalable with EDC, eConsent, ePRO & eCOA + DCT integrations. These solutions enable researchers to easily capture and integrate data from any source and decentralize their trials. Highlights: -Build studies within hours leveraging pre-built templates -Integrate EMR/EHR, patient, clinician, device, and wearable data -90% of studies in Castor are built and pass UAT in less than 4 weeks, significantly faster than the industry benchmark More than 40,000 researchers across 90 countries are using Castor to supercharge their research. Castor`s platform has supported more than 8,500 studies that cover a broad range of disease areas including diabetes, cardiovascular disease, central nervous system (CNS), rare diseases, infectious diseases, and oncology.